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Abstract
Background: High glucose induced lipid synthesis leads to b cell glucolipotoxicity. Sterol regulatory element
binding protein-1c (SREBP-1c) is reported to be partially involved in this process. Insulin induced gene-1 (Insig-1) is
an important upstream regulator of Insig-1-SREBPs cleavage activating protein (SCAP)-SREBP-1c pathway. Insig-1
effectively blocks the transcription of SREBP-1c, preventing the activation of the genes for lipid biosynthesis. In this
study, we aimed to investigate whether Insig-1 protects b cells against glucolipotoxicity.
Methods: An Insig-1 stable cell line was generated by overexpression of Insig-1 in INS-1 cells. The expression of
Insig-1 was evaluated by RT-PCR and Western blotting, then, cells were then treated with standard (11.2 mM) or
high (25.0 mM) glucose for 0 h, 24 h and 72 h. Cell viability, apoptosis, glucose stimulated insulin secretion (GSIS),
lipid metabolism and mRNA expression of insulin secretion relevant genes such as IRS-2, PDX-1, GLUT-2, Insulin
and UCP-2 were evaluated.
Results: We found that Insig-1 suppressed the high glucose induced SREBP-1c mRNA and protein expression. Our
results also showed that Insig-1 overexpression protected b cells from ER stress-induced apoptosis by regulating
the proteins expressed in the IRE1a pathway, such as p-IRE1a, p-JNK, CHOP and BCL-2. In addition, Insig-1 up-
regulated the expression of IRS-2, PDX-1, GLUT-2 and Insulin, down-regulated the expression of UCP-2 and
improved glucose stimulated insulin secretion (GSIS). Finally, we found that Insig-1 inhibited the lipid accumulation
and free fatty acid (FFA) synthesis in a time-dependent manner.
Conclusions: There results suggest that Insig-1 may play a critical role in protecting b cells against
glucolipotoxicity by regulating the expression of SREBP-1c.
Background
Pancreatic b cell dysfunction is a crucial pathological
contributor to the development of type 2 diabetes. The
effects of glucose and free fatty acid (FFA) on b cell dys-
function have been extensively studied [1-4]. Chronic
exposure to high glucose or high lipid leads to “gluco-
toxicity” or “lipotoxicity” [5]. The term “glucolipotoxi-
city” is now widely accepted to describe the combined
effects of high glucose and high lipid on b cell dysfunc-
tion [6]. Apoptosis, impaired glucose stimulated insulin
secretion (GSIS) [7] and lipid accumulation [8] are criti-
cal components involved in glucolipotoxicity.
Sterol regulatory element binding protein-1c (SREBP-
1c), a lipogenic transcription factor, has been found to
play a critical role in the development of b cell
dysfunction caused by elevated glucose and FFA [9].
SREBP-1c is a membrane-bound transcription factor
from the basic helix-loop-helix (bHLH) leucine zipper
family and has been described as a regulator of lipogenic
enzymes in liver, adipocytes, myocytes and b cells [10].
Overexpression of SREBP-1c induced b cell dysfunction,
such as apoptosis, GSIS and lipid accumulation [9,11].
SREBP-1c preferentially activates genes involved in FFA
and triglyceride synthesis, like fatty acid synthesis (FAS),
elongation of very long-chain fatty acids (ELOVL), and
Δ5-desaturase (DSR5) [12,13]. First, high glucose up-
regulates the synthesis of FFA and leads to b cell apop-
tosis. Several mechanisms are implicated in this process,
such as ER stress, oxidative stress, ceramide formation
and modulation of microRNAs pathways [14-17]. ER
stress mechanism is When FFA activates misfolded pro-
teins in the ER lumen, Igheavy chain binding protein
(BIP) dissociates from ER stress transducers. BIP then
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inositol requiring ER-to-nucleus signal kinase 1a
(IRE1a), activating transcription factor (ATF6), and
PKR-like ER kinase (PERK), the UPR is activated. The
IRE1a then activates c-Jun N-terminal kinase (JNK), C/
EBP homologous protein (CHOP), inhibits BCL-2 and
results in apoptosis [18]. Second, increased FFA synth-
esis results in impaired GSIS. SREBP-1c is implicated to
be involved through regulation of insulin receptor sub-
strate 2 (IRS-2), pancreatic duodenal homeobox factor-1
(PDX-1) and uncoupling protein-2 (UCP-2) [19].
SREBP-1c directly regulates the transcription of the
genes mentioned above and glucose transporter iso-
form-2 (GLUT-2) through sterol response element
(SRE). GLUT-2 takes up glucose thereby increases ATP
and ultimately up-regulates the expression of insulin [8].
Third, SREBP-1c regulates lipid synthesis in b cell. High
glucose both acutely and chronically induces de novo
lipogenesis, and activates SREBP-1c transcription of
lipid synthesis [20].
Insulin induced gene-1 (Insig-1), an ER-resident pro-
tein that contains six transmembrane segments, nega-
tively regulates SREBPs and HMG-CoA reductase, and
plays a critical role in the feedback control of lipid
synthesis. Sterol-stimulated binding of Insig-1 to
SREBPs cleavage activating protein (SCAP) facilitates
the retention of SCAP/SREBP-1c complex in the ER,
prevents SREBP-1c from entering into the Golgi appara-
tus, decreases production of the nuclear forms of
SREBPs (nSREBPs) and limits transcription of SREBP-1c
target genes [21]. Therefore, Insig-1 is an important
upstream factor, which regulates lipid synthesis via
Insig-1-SCAP-SREBP pathway. Overexpression of Insig-
1 has been found to inhibit lipid synthesis both in vitro
and in vivo experiments [22], however, it is still unclear
whether Insig-1 regulates b cell function at SREBP-1c
level.
The present study was performed to comprehensively
investigate whether overexpression of Insig-1 protects b
cells against glucolipotoxicity via SREBP-1c. Insig-1
stable transfected INS-1 cells were generated and the
cell viability, apoptosis, insulin secretion, lipid metabo-
lism and mRNA expression of relevant genes such as
IRS-2, PDX-1, GLUT-2, Insulin and UCP-2 were
evaluated.
Materials and methods
Plasmid construction
The mouse Insig-1 cDNA fragment was generated by
RT-PCR. Total RNA was extracted from mouse 3T3-L1
cells using TRIzol Reagent (Invitrogen, USA) following
manufacture’s instructions. Total RNA was reverse tran-
scribed using moloney murine leukemia virus reverse
transcriptase (Fermentas, USA). Fragments of mouse
Insig-1 (NM-153526.5) cDNA were amplified by PCR
using the following primers: forward5’-GAAGCT-
TATGCCCAGGCTGC-3’ and reverse 5’-GAATTCTTC-
CACTCTGAACCATGT-3’. Hind III and EcoR I
restriction sites were included (underlined) to facilitate
the ligation of cDNA product into pcDNA3.1(+) vector
(Invitrogen, USA). The mouse Insig-1 primers used in
this study were tested using Blast software (http://blast.
ncbi.nlm.nih.gov/Blast.cgi), and did not recognize the rat
Insig-1 mRNA sequence. The sequence of pcDNA3.1
(+)-Insig-1 was verified by DNA sequencing.
Cell culture and generation of stable transfection cell line
Rat pancreatic INS-1 cells were maintained in RPMI
1640 medium (Gibco-BRL, U.K.) with 11.2 mM glucose
supplemented with 10% heat-inactivated fetal calf
serum, 10 mM HEPES, 2 mM L-glutamine, 1 mM
sodium pyruvate, 50 μΜ b-mercaptoethanol, 100 U/ml
penicillin and 100 mg/ml streptomycin at 37°C in a
humidified atmosphere (5% CO2 and 95% air).
To generate an Insig-1 overexpression INS-1 cell line
(INS-1-Insig-1), INS-1 cells were transfected with
pcDNA3.1(+)-Insig-1. In brief, INS-1 cells were plated
in a six-well plate and grown overnight to approximately
60% confluency. Cells were transfected using Lipofecta-
mine 2000 (Invitrogen, USA) and 1.6 μgD N Ap e rw e l l
in serum-free medium according to the manufacturer’s
instructions. After 48 h, cells were subjected to 100 μg/
ml G418 selection for 30 days. Stable transfection cell
line was derived from a single stable clone. Insig-1 gene
and protein expression were confirmed by RT-PCR and
Western blot analysis, respectively.
To study the effects of Insig-1 on glucose-induced glu-
colipotoxicity on b cell, INS-1-Insig-1 cells and control
INS-1 cells were incubated in RPMI medium at 11.2
mM or 25.0 mM glucose for 0, 24 and 72 h.
MTT assay
Cell viability was measured by adding 200 g/ml 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) (Dingguo, China) to INS-1 cells and INS-1-
Insig-1 cells, and incubated for 3 h at 37°C. The reaction
was stopped and the purple formazan precipitate formed
was dissolved using dimethyl sulfoxide (DMSO) and the
color intensity was measured at 550 nm using a multi-
well spectrophotometer (Thermo Labsystems, USA).
Detection of apoptotic cells
For flow cytometric analysis, cells were collected by
trypsinization and washed with cold phosphate-buffered
saline and incubated for 10 min with Annexin V (Sigma,
USA) for 15 min, then stained with propidium iodide
(PI) (Sigma, USA). The analysis was performed with a
FACScan flow cytometer (BD Biosciences, USA) using
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in early apoptosis are Annexin V positive and PI
negative.
Western blot analysis
Proteins were extracted as previously described [23,24].
Briefly, cells were washed twice with PBS, and protein
was extracted using lysis buffer (Sigma, USA). The
supernatant was obtained by centrifugation at 4°C,
12,000 rmp for 10 minutes. The nuclear protein was
extracted using a nuclear protein extraction kit (Gen-
eray, China) according to the manufacture’sp r o t o c o l .
Proteins were resolved by SDS-PAGE and were trans-
ferred to nitrocellulose membranes. After incubation
w i t hp r i m a r ya n t i b o d ya n ds e c o n d a r ya n t i b o d yc o n j u -
gated to horseradish peroxidase, the bands were
detected with the enhanced chemiluminescence system
(Amersham Bioscience, USA). Immunoblots were
scanned and quantified using Scion Image software
(Scion Corporation, USA). The following primary anti-
bodies (Santa Cruz Biotechnology or Novus Biologicals,
USA) and dilution were used: Insig-1 (sc-51102, 1:500),
nSREBP-1 (sc-8984, 1:300), p-JNK(sc-6254, 1:100),
CHOP (sc-575, 1:500), BCL-2 (sc-7382, 1:200), GAPDH
(sc-47724, 1:200) and p-IRE1a (NB100-2323, 1:500).
Glucose stimulated insulin secretion (GSIS)
After exposure to the indicated glucose (11.2 mM or
25.0 mM) for 0, 24 and 72 h, two groups of cells were
washed twice with PBS, followed by pre-incubation in
Krebs-Ringer bicarbonate HEPES buffer (KRBH buffer:
115 mM NaCl, 24 mM NaHCO3, 5 mM KCl, 1 mM
MgCl2, 25 mM HEPES, 0.5% BSA, pH 7.4) containing 3
mM glucose at 37°C for 30 min. The buffer was
removed completely and collected for basal insulin
secretion measurement. Fresh KRBH buffer containing
20 mM glucose was then added to the cells and cells
were incubated for an additional 30 min as glucose sti-
mulated insulin secretion. Insulin concentration was
measured using an insulin radioimmunoassay (RIA) kit
(Beijing Atom HighTech, China) according to the manu-
facture’s protocol.
Total RNA preparation and real-time PCR
Total RNA was extracted and reverse transcribed as
described above. Real-timeP C Rw a sp e r f o r m e du s i n g
QuantiTect SYBR green PCR master mix kit (ToYoBo,
Japan) following the manufacturer’si n s t r u c t i o n so na
mastercycler EP realplex RT-PCR instrument (Eppen-
dorf, Germany). The reaction volume was 10 μLa n d
contained 5 μL QuantiTect SYBR green PCR master
mix, 0.5 μmol/L primers and 100 ng cDNA and RNase-
free water. Primer sequences used in the PCR are pro-
vided in Table 1. The PCR conditions were: an initial
denaturation at 95°C for 1 min, followed by 40 PCR
cycles. Each cycle consisted of 15 s at 95°C, 30 s at 60°C
and 30 s at 72°C. All quantifications were performed
with rat GAPDH as an internal standard. The relative
amount of all mRNA was calculated using the 2-ΔΔCT
method.
Oil Red O staining and measurement of FFA content
Cells were fixed with 10% (v/v) formalin and were
s t a i n e dw i t hO i lR e dOa sd e s c r i b e db yK u r i - H a r c u c h
and Green [25]. Lipid droplets were observed and
photographed under a microscope (TE2000-E; Nikon).
At the end of 0, 24 and 72 h incubation, media were
collected and FFA content of each sample was
Table 1 Sequence information on the primers used for real-time PCR
Gene name Sequences for forward and reverse primers (5’-3’) Gene Bank accession number
SREBP-1c GGAGCCATGGATTGCACATT L16995
AGGCCAGGGAAGTCACTGTCT
IRS-2 CCACACGCCTTTCGCTAGA XM-573948
GTACCCCCTTCACCAAAGTCAA
UCP-2 GCATTGGCCTCTACGACTCT NM-019354.2
CTGGAAGCGGACCTTTACC
PDX-1 AAACGCCACACACAAGGAGAA NM-022852
AGACCTGGCGGTTCACATG
GLUT-2 CAGCTGTCTCTGTGCTGCTTGT NM-012879
GCCGTCATGCTCACATAACTCA
Insulin TCTTCTACACACCCATGTCCC NM-019130
GGTGCAGCACTGATCCAC
FAS GCTGCTGCTGTGGACCTCAT X62888
TTTATACTGGTCGGCGGCTC
GAPDH TGGTGGACCTCATGGCCTAC XM-344448
CAGCAACTGAGGGCCTCTCT
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ing to the manufacturer’s protocol.
Statistical analysis
Data shown are means ± SE. Statistical significance of
differences between two groups was determined using
the Student’s t-test. Groups of three or more were ana-
lyzed by one-way ANOVA. P value of less than 0.05 was
considered significant.
Results
mRNA and protein expression of Insig-1 in INS-1 cells
overexpressed with Insig-1
To determine the transfection efficiency, we analyzed
protein and mRNA expression of mouse Insig-1 in INS-
1-Insig-1 cells. The Insig-1 primary antibody was mouse
specific and did not cross react with rat Insig-1 protein.
The Western blot results showed that Insig-1 protein
was not expressed in control INS-1 cells, while mouse
Insig-1 was highly expressed in two randomly selected
stable cell lines with Insig-1 overexpression (sample 1
and 2), and the expression was especially high in sample
2 (Figure 1A, B). Similarly, mouse Insig-1 mRNA was
not expressed in control INS-1 cells, but the 819 bp
mouse Insig-1 fragment was detected in INS-1-Insig-1
stable cell lines (especially in sample 2) which was in
accordance with our original design (Figure 1C). Sample
2 was thus selected as our INS-1-Insig-1 stable cell line
for further experiment.
Insig-1 increases cell viability and decreases apoptosis
against glucolipotoxicity
To determine the effect of Insig-1 overexpression on cell
viability and apoptosis, INS-1 cells and INS-1-Insig-1
cells were exposed to 11.2 and 25.0 mM glucose for 0,
24 and 72 h, respectively. The MTT assay results
showed no difference in cell viability of those two
groups at 11.2 mM glucose fora l lt h r e et i m ep o i n t s .
Interestingly, after 72 h incubation in 25.0 mM glucose,
the cell viability of control INS-1 cells was significantly
decreased by 30%, and decreased by only 14% in INS-1-
Insig-1 cells (P < 0.05 vs INS-1 cells), (Figure 2A). Simi-
lar results were also detected by flow cytometric analy-
sis, 24 h and 72 h treatment with 25.0 mM glucose
caused a drastically increase of apoptosis in both control
INS-1 cells, however, less apoptosis was found in INS-1-
Insig-1 cells (13.1 ± 1.9% vs. 8.6 ± 2.1% for 24 h, 20.4 ±
2.5% vs. 10.9 ± 1.2% for 72 h, respectively, Figure 2B),
suggesting that Insig-1 overexpression protected b cell
viability and apoptosis against chronic high glucose
induced glucolipotoxicity.
Insig-1 suppresses nSREBP-1c expression and decreases
ER stress through IRE1a pathway
To further investigate the underlying molecular mechan-
isms by which Insig-1 prevents b cell apoptosis, we
examined the expression of nSREBP-1c, a nuclear active
form of SREBP-1c. Cell total nuclear protein was
extracted and SREBP-1c protein expression was evalu-
ated by Western bolt analysis. The results showed that
nSREBP-1c protein expression was significantly less up-
regulated in control INS-1 cells exposed to 25.0 mM
glucose for 24 h and 72 h, while in INS-1-Insig-1 cells,
nSREBP-1c was significantly down-regulated when
exposed to standard (11.2 mM) or high (25.0 mM) glu-
cose compared to control INS-1 cells at all time points.
We also examined ER stress related protein expression
Figure 1 Detection of Insig-1 mRNA and protein expression in
INS-1-Insig-1 stable cells. An Insig-1 stable cell line was generated
by overexpression of Insig-1 in INS-1 cells, Insig-1 gene and protein
expression were confirmed by RT-PCR and Western blot analysis,
respectively. A) A mouse specific anti-Insig-1 primary antibody was
used to detect mouse Insig-1 protein by Western blot analysis.
GAPDH was used as control for protein loading. B) Relative
expression of Insig-1 protein compared to GAPDH. 1, 2 and 3
represent control INS-1 cells, INS-1-Insig-1 cell line 1 and 2,
respectively. *P < 0.05. C) Mouse Insig-1 mRNA expression was
detected by RT-PCR, INS-1-Insig-1 cell line 2 is shown and used for
further experiments. M: Marker.
Figure 2 Insig-1 increased cell viability and decreased cell
apoptosis in the presence of high glucose induced
glucolipotoxicity. INS-1 and INS-1-Insig-1 cells were stimulated
with 11.2 and 25.0 mM glucose for 0, 24 and 72 h. A) Cell viability
was measured by MTT assay, B) Cell apoptosis rates were detected
by flow cytometric analysis. *P < 0.05; **P < 0.01 VS INS-1 cell at the
same time point.
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there was no change in CHOP expression between these
two groups of cells at all three time points, while 25.0
mM glucose significantly decreased CHOP expression at
24 and 72 h in INS-1-Insig-1 cells compared to control
INS-1 cells. The expression of p-IRE1a and P-JNK
expression in INS-1-Insig-1 cells was significantly
decreased compared to control INS-1 cells in every time
points when exposed to standard (11.2 mM) or high
(25.0 mM) glucose. However, BCL-2 expression in INS-
1-Insig-1 cells was significantly increased compared to
control INS-1 cells (Figure 3A, B). These results sug-
gested that overexpression of Insig-1 down regulated the
expression of nSREBP-1c, suppressed the IRE1a path-
way of ER stress and prevented b cells from apoptosis.
Insig-1 improved the GSIS in INS-1 cells
To further investigate the effect of Insig-1 overexpres-
sion on insulin secretion, we measured the basal and
GSIS in INS-1 and INS-1-Insig-1 cells. Cells were
exposed to 11.2 or 25.0 mM glucose for 0, 24 and 72 h.
There was no difference on basal insulin secretion
between INS-1 and INS-1-Insig-1 cells after 11.2 mM or
25.0 mM glucose incubation for 0, 24 or 72 h. However,
GSIS was markedly reduced (20.4% vs. 13.3% for 24 h,
39% vs. 21.7% for 72 h, respectively) after 24 and 72 h
exposure to 25.0 mM glucose in both INS-1 and INS-1-
Insig-1 cells. After 72 h stimulation with 25.0 mM glu-
cose, the GSIS in control INS-1 cells decreased more
dramatically compared with INS-1-Insig-1 cells (Figure
4). These results suggested that Insig-1 improved
impaired GSIS induced by high glucose in INS-1 cells.
Insig-1 regulates the expression of insulin secretion genes
and FAS via SREBP-1c
To determine the molecular mechanisms by which
Insig-1 improved insulin secretion and prevented the
lipid synthesis, mRNA expression of insulin secretion
related genes, such as IRS-2, PDX-1, GLUT-2, Insulin
and UCP-2 were evaluated by real-time PCR. The
results showed that SREBP-1c mRNA expression in
both INS-1 and INS-1-Insig-1 cells was significantly up-
regulated after 25.0 mM glucose stimulation, while in
INS-1-Insig-1 cells, SREBP1-c mRNA was significantly
down-regulated compare to that of control INS-1 cells
upon treatment with 11.2 mM or 25.0 mM glucose and
these effects were much prominent in 25.0 mM glucose
at 72 h (Figure 5A). The insulin secretion related genes
IRS-2, PDX-1 and GLUT-2 were also significantly up-
regulated. When exposed to 11.2 mM or 25.0 mM glu-
cose, IRS-2 mRNA level increased 1.52 - 5.31 fold (Fig-
ure 5B), PDX-1 mRNA level increased 1.23 - 2.86 fold
(Figure 5C) and GLUT-2 mRNA level increased 2.18 -
5.10 fold at 0 h, 24 h and 72 h (Figure 5D), respectively.
Although insulin mRNA expression was not changed by
incubation with 11.2 mM glucose, it revealed a 1.59 and
1.82 fold increase with 25.0 mM glucose for 24 h and
72 h, respectively (Figure 5E). The mRNA level of UCP-
2, a negative modulator of insulin secretion, decreased
49% -70% (Figure 5F). FAS is one of the most important
lipid synthesis genes, the mRNA level of FAS decreased
by 21% - 65% in INS-1- Insig-1 cells (Figure 5G). These
results implicated that Insig-1 regulated insulin secretion
and lipid genes expression through SREBP-1c.
Insig-1 inhibits intracellular accumulation of lipid droplets
and reduces FFA synthesis
We further assessed whether Insig-1 prevented lipid
accumulation and FFA synthesis. Intracellular lipid
accumulation was evaluated by Oil Red O staining and
light microscopy. FFA concentration was measured
using ELISA. No lipid droplets were observed at 11.2
mM glucose in those two groups of cells (data of con-
t r o lI N S - 1c e l l sa t2 4a n d7 2hw e r en o ts h o w n ) ,a n d
few lipid droplets were detected following 25.0 mM glu-
cose exposure for 24 h. Interestingly, a large amount of
lipid droplets were accumulated in the cytoplasm by the
end of 72 h following 25.0 mM glucose exposure. It
should be noted that, INS-1-Insig-1 cells demonstrated
less lipid droplets compared with control INS-1 cells
(Figure 6A). No difference in FFA concentration was
detected in the media of the cells exposed to 11.2 mM
glucose, while FFA concentration was significantly
increased by 25.0 mM glucose stimulation for 24 h and
72 h, and INS-1-Insig-1 cells showed less FFA concen-
tration compared to control INS-1 cells (48.76 ± 5.64
vs. 63.50 ± 7.23 μmol/L in 24 h, 94.81 ± 4.12 vs. 158.43
±1 0 . 7 7μmol/L in 72 h) (Figure 6B). These results indi-
cated that high glucose induced FFA production, which
leads to glucolipotoxicity in INS-1 cells, was attenuated
by Insig-1 overexpression.
Discussion
In the present study, we overexpressed Insig-1 in INS-1
cells and investigated the role of Insig-1 in glucolipo-
toxicity and demonstrated that Insig-1 partially
improved b cell dysfunction induced by high glucose.
Glucolipotoxicity is an important factor in b cell dys-
function [26]. SREBP-1c is a critical component involved
in this process and has been examined extensively. We
hypothesized that the potential mechanism is that high
glucose induces lipid accumulation through SREBP-1c
and leads to b cell dysfunction, which is accompanied
by apoptosis, impaired GSIS and lipid accumulation [9].
Overexpression of SREBP-1c has been found to induce
glucolipotoxicity in insulinoma cells (INS-1 and MIN6)
and isolated rat islets [27]. Insig-1 acts as an upstream
regulator of SREBP-1c and regulates lipid metabolism
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experiments showed that overexpression of Insig-1 pre-
vented lipogenesis and inhibited differentiation of prea-
dipocyte 3T3-L1 cells [28]. Furthermore, an in vivo
study using recombinant adenovirus containing mouse
Insig-1 cDNA transfected Zucker diabetic fatty (ZDF)
(fa/fa) rats resulted in a striking reduction of lipid synth-
esis in liver [29].
To investigate the underlying molecular mechanism of
Insig-1 in preventing b cell apoptosis, we examined the
expression of SREBP-1c mRNA and protein in control
INS-1 cells and INS-1-Insig-1 cells under different
Figure 3 Effect of Insig-1 overexpression on nSREBP-1c and proteins related to ER stress pathway in INS-1 cells. INS-1 and INS-1-Insig-1
cells were stimulated with 11.2 mM and 25.0 mM glucose for 0, 24 and 72 h. A) nSREBP-1c and p-IRE1a pathway of ER stress related proteins
were detected by Western blot. GAPDH was used as control for protein loading. Equal amount of proteins (50 μg) were loaded. B) Relative
protein expression compared to GAPDH, data are the means ± SE of three independent experiments; *, P < 0.05, **, P < 0.01 VS INS-1 cells at
the same time point.
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sion of SREBP-1c were increased after 25.0 mM glucose
stimulation in INS-1 and INS-1-Insig-1 cells, while INS-
1-Insig-1 cells showed less SREBP-1c expression at all
time points compared to control INS-1 cells, which is
consistent with previous findings by others [27,28]. This
suggests that overexpression of Insig-1 strongly sup-
presses SREBP-1c expression. We also assessed ER stress
related protein expression in p-IRE1a pathway. ER stress
plays an important role in b cell apoptosis. Wang et al.
o b s e r v e dt h a tt h et r e a t m e n to f isolated rat islets with
high glucose or ER stress inducers, drastically increased
SREBP-1c activity, and the induction of a dominant nega-
tive mutant of SREBP-1c prevented high glucose induced
ER stress [23]. Several studies have shown the p-IRE1a
pathway which involves p-JNK activation, CHOP up-reg-
ulation and BCL-2 down-regulation in the process of
apoptosis [29,30]. We observed that after exposing to
Figure 4 Improvement of GSIS by Insig-1 overexpression. INS-1
and INS-1-Insig-1 cells were cultured in RPMI 1640 with different
glucose concentrations for 0, 24 and 72 h, medium were then
changed to KRBH containing 3 mM and 20 mM glucose and then
collected for basal and glucose stimulated insulin secretion. Insulin
concentration was determined by rat insulin RIA. * P < 0.05; ** P <
0.01 VS exposed to 11.2 mM glucose at the same time point; # P <
0.05 VS INS-1 cells exposed to 25.0 mM glucose at the same time
point.
Figure 5 Overexpression of Insig-1 suppressed SREBP-1c transcription and affected mRNA expression of insulin secretion genes. Two
groups of cells were exposed to 11.2 mM or 25.0 mM glucose for 0, 24 and 72 h, mRNA level of insulin secretion genes and FAS was detected
by real-time PCR. A-G represented SREBP-1c, IRS-2, PDX-1, GLUT-2, insulin, UCP-2 and FAS mRNA fold change in INS-1-Insig-1 cells compared to
INS-1 cells. * P < 0.05, ** P < 0.01 VS control INS-1 cells at the same time point.
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up-regulated, while BCL-2 were down-regulated in both
INS-1 and INS-1-Insig-1 cells and Insig-1 overexpression
cells showed less change compared with INS-1 cells.
Thus, our study showed that overexpression of Insig-1
could strongly suppress p-IRE1a, p-JNK and CHOP pro-
tein expression after exposure to high glucose. At
standard glucose level(11.2 mM), p-IRE1a and p-JNK
protein expression were both down-regulated in INS-1-
Insig-1 cells compared with INS-1 cells at all time points,
while the protein expression of BCL-2 in INS-1-Insig-1
cells showed up-regulation compared to control INS-1
cells, though there was no difference in CHOP expres-
sion. We therefore postulated that even normal glucose
Figure 6 Detection of intracellular lipid droplets in INS-1 cells by light microscopy and FFA measurement. The INS-1 and INS-1-Insig-1
cells were exposed to 11.2 mM or 25.0 mM glucose for 0, 24 and 72 h. A) Oil Red O staining. The lipid droplets are stained dark red.
(Magnification × 100) B) FFA concentration in the medium was measured by ELISA. * P < 0.05; ** P < 0.01 VS exposed to 11.2 mM glucose at
the same time point; # P < 0.05 VS INS-1 cells at the same time point.
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IRE1a pathway at this time.
SREBP-1c participates in multiple regulatory mechan-
isms of GSIS. In vitro, overexpression of SREBP-1c
results in impaired insulin secretion in isolated rat islets
[31]. In vivo, similar results were also observed by Taka-
hashi et al. by using transgenic mice overexpressing the
active form of SREBP-1c [32]. In addition, SREBP-1c
knockout mice had increased basal and high glucose sti-
mulated insulin secretion [33]. SREBP-1c also regulates
the expression of insulin genes [34]. Recently, it was
demonstrated that IRS-2, a gene plays an important role
in b cell growth and survival, participated in GSIS
through direct binding of SREBP-1c to its promoter
[35]. Furthermore, both in vitro and in vivo experiments
showed that overexpression of SREBP-1c could suppress
the expression of PDX-1, a crucial transcription factor
of insulin secretion [36]. It was also observed that high
nutrition could accumulate the expression of UCP-2, a
regulator of cytoplasmic ATP/ADP ratio in the process
of GSIS, through SREBP-1c [34]. GLUT-2 is known as a
transporter of glucose, and is activated upon binding
with SREBP-1c [37]. Our results showed that in INS-1-
Insig-1 cells, IRS-2, PDX-1 and GLUT-2 mRNA expres-
sions were increased to various degrees compared with
control INS-1 cells. The change in UCP-2 mRNA
expression was similar to and in accordance with that of
SREBP-1c, and although drastically increased at 25.0
mM glucose. Insulin mRNA expression did not increase
when exposed to standard 11.2 mM glucose stimulation.
These results are consistent with our mRNA study indi-
cating that overexpression of Insig-1 decreased insulin
secretion only after exposure to high glucose and we
therefore postulated that other mechanisms might also
be involved.
We measured the FFA concentration to further eluci-
date whether Insig-1 could suppress the lipid accumula-
tion and FFA synthesis. Wang et al. [26] confirmed that
chronic exposure to high glucose for 72 h induced lipid
accumulation in INS-1 cells by increasing lipogenic gene
expression, while chronic incubation with 1.5 mM FFA
(2:1 oleate/palmitate) did not obtain the same results
[38]. Our results showed a significantly increase of lipid
droplets accumulation and FFA concentration after
exposing to 25.0 mM glucose for 24 h and 72 h. We
also verified that chronic high glucose induced FFA
synthesis participated in b cell glucolipotoxicity, and this
process was partially prevented by overexpression of
Insig-1. FFA concentration and lipid accumulation in
INS-1-Insig-1 cell were significantly decreased compare
to that of control INS-1 cells.
We observed more drastically effect when two groups
cultured for 72 h than 24 h, especially when INS-1 cells
exposed to 25.0 mM glucose, for example, enhanced
early cell apoptosis rate, an ER stress response, an inhi-
bition of GSIS, an accumulation of intracellular lipid
droplets and so on. We therefore postulate that high
glucose stimulates more FFA, leads to lipotoxicity, and
subsequently induces the impairment of beta cells.
Conclusion
In summary, our results demonstrated that b cell dys-
function through chronic exposure of high glucose
could be inhibited by Insig-1. The process may involve
reducing cell apoptosis and increasing cell viability, pre-
venting lipid accumulation and improving impaired
GSIS. One possible molecular mechanism is that Insig-1
suppresses high glucose induced SREBP-1c transcrip-
tion, which leads to reduced FFA and other lipid pro-
duction, decreases expression of ER stress pathway
protein and up-regulates the expression of insulin secre-
tion genes. In conclusion, overexpression of Insig-1 pro-
tects b cells against glucolipotoxicity via SREBP-1c, thus
improvement of Insig-1 activity should be considered as
a therapy aimed at b cell protection.
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